Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-May-15 7:52 PM View:  | Santel Donald J CEO & President Director | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition | 345,932 | $46.00 | $15,912,900.00 | (97%) 358.4K to 12.47K | < 1% |
| 11-May-15 3:00 PM View: | Kerins Patrick J 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 120 | $46.00 | $5,520.00 | (100%) 0.12K to 0 | < 1% |
| 08-May-15 9:05 PM View: | Healy James Director 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition | 2,617 | $46.00 | $120,382.00 | (< 1%) 1.95M to 1.94M | < 1% |
| 08-May-15 7:52 PM View: | Santel Donald J CEO & President Director | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 2,306 | $46.00 | $106,076.00 | (18%) 12.47K to 10.16K | < 1% |
| 11-May-15 3:00 PM View: | Sandell Scott D 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) Duplicate | 2,384,220 | $46.00 | $109,674,000.00 | (100%) 2.38M to 0 | < 1% |
| 08-May-15 8:00 PM View: | Scharschmidt Bruce Frederick SVP & Chief Medical Officer | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 24,448 | $46.00 | $1,124,610.00 | (100%) 24.45K to 0 | < 1% |
| 08-May-15 9:05 PM View: | Healy James Director 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) Duplicate | 1,939,470 | $46.00 | $89,215,800.00 | (100%) 1.94M to 0 | < 1% |
| 08-May-15 7:58 PM View: | Gould Ashley C. SVP Govt Aff & Chief Legal Ofc | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition | 21,775 | $46.00 | $1,001,650.00 | (96%) 22.58K to 0.8K | < 1% |
| 08-May-15 7:47 PM View: | Nash Christine A SVP & Chief Commercial Officer | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition | 84,587 | $46.00 | $3,891,000.00 | (88%) 96.09K to 11.5K | < 1% |
| 11-May-15 3:01 PM View: | Drant Ryan D 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 30 | $46.00 | $1,380.00 | (100%) 30 to 0 | < 1% |
| 08-May-15 7:55 PM View: | Holles Natalie C. SVP, Business Development | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition | 17,750 | $46.00 | $816,500.00 | (96%) 18.45K to 0.7K | < 1% |
| 08-May-15 7:57 PM View: | Zoth Lota S Director | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition | 2,617 | $46.00 | $120,382.00 | (100%) 2.62K to 0 | < 1% |
| 08-May-15 7:52 PM View: | Santel Donald J CEO & President Director | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 10,164 | $46.00 | $467,544.00 | (100%) 10.16K to 0 | < 1% |
| 11-May-15 3:00 PM View: | Barrett M James 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) Duplicate | 2,384,220 | $46.00 | $109,674,000.00 | (100%) 2.38M to 0 | < 1% |
| 11-May-15 3:01 PM View: | Drant Ryan D 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) Duplicate | 2,384,220 | $46.00 | $109,674,000.00 | (100%) 2.38M to 0.3K | < 1% |
| 11-May-15 2:52 PM View: | New Enterprise Associates 1... 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 2,384,220 | $46.00 | $109,674,000.00 | (100%) 2.38M to 0 | < 1% |
| 08-May-15 7:52 PM View: | Hansen Bo Jesper Director | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition | 2,617 | $46.00 | $120,382.00 | (100%) 2.62K to 0 | < 1% |
| 08-May-15 7:48 PM View: | Salehizadeh Bijan Director | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition | 2,617 | $46.00 | $120,382.00 | (100%) 2.62K to 0 | < 1% |
| 08-May-15 7:59 PM View: | Sofinnova Venture Partners ... 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 1,939,470 | $46.00 | $89,215,800.00 | (100%) 1.94M to 0 | < 1% |
| 11-May-15 2:53 PM View: | Nunn Jason Raleigh Director | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 70 | $46.00 | $3,220.00 | (100%) 70 to 0 | < 1% |
| 11-May-15 3:01 PM View: | Barris Peter J 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 2,384,510 | $46.00 | $109,688,000.00 | (100%) 2.38M to 0 | < 1% |
| 08-May-15 7:58 PM View: | Schroeder Theodore R Director | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition | 3,083 | $46.00 | $141,818.00 | (83%) 3.7K to 0.62K | < 1% |
| 11-May-15 3:00 PM View: | Kerins Patrick J 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) Duplicate | 2,384,220 | $46.00 | $109,674,000.00 | (100%) 2.38M to 0.12K | < 1% |
| 08-May-15 7:47 PM View: | Farrow Jeffrey S CFO | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition | 143,464 | $46.00 | $6,599,340.00 | (99%) 144.34K to 0.88K | < 1% |
| 08-May-15 7:47 PM View: | Farrow Jeffrey S CFO | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 878 | $46.00 | $40,388.00 | (100%) 0.88K to 0 | < 1% |
| 08-May-15 8:00 PM View: | Scharschmidt Bruce Frederick SVP & Chief Medical Officer | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 97,471 | $46.00 | $4,483,670.00 | (80%) 121.92K to 24.45K | < 1% |
| 08-May-15 9:05 PM View: | Healy James Director 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 5,006 | $46.00 | $230,276.00 | (< 1%) 1.94M to 1.94M | < 1% |
| 11-May-15 3:01 PM View: | Drant Ryan D 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 266 | $46.00 | $12,236.00 | (90%) 0.3K to 30 | < 1% |
| 08-May-15 7:58 PM View: | Gould Ashley C. SVP Govt Aff & Chief Legal Ofc | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 801 | $46.00 | $36,846.00 | (100%) 0.8K to 0 | < 1% |
| 11-May-15 3:01 PM View: | Baskett Forest 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) Duplicate | 2,384,220 | $46.00 | $109,674,000.00 | (100%) 2.38M to 0 | < 1% |
| 08-May-15 7:46 PM View: | Welch Daniel G Director | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition | 2,617 | $46.00 | $120,382.00 | (100%) 2.62K to 0 | < 1% |
| 08-May-15 7:55 PM View: | Holles Natalie C. SVP, Business Development | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 702 | $46.00 | $32,292.00 | (100%) 0.7K to 0 | < 1% |
| 11-May-15 2:59 PM View: | Kolluri Krishna Kittu 10% Owner | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) Duplicate | 2,384,220 | $46.00 | $109,674,000.00 | (100%) 2.38M to 0 | < 1% |
| 08-May-15 8:00 PM View: | Scharschmidt Bruce Frederick SVP & Chief Medical Officer | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition | 25,025 | $46.00 | $1,151,150.00 | (17%) 146.94K to 121.92K | < 1% |
| 11-May-15 2:53 PM View: | Nunn Jason Raleigh Director | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition | 2,617 | $46.00 | $120,382.00 | (97%) 2.69K to 70 | < 1% |
| 08-May-15 7:47 PM View: | Nash Christine A SVP & Chief Commercial Officer | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 11,503 | $46.00 | $529,138.00 | (100%) 11.5K to 0 | < 1% |
| 08-May-15 7:58 PM View: | Schroeder Theodore R Director | Hyperion Therapeutics Inc (HPTX) | 07-May-15 | Disposition (change in control) | 617 | $46.00 | $28,382.00 | (100%) 0.62K to 0 | < 1% |
| 08-May-15 9:05 PM View: | Healy James Director 10% Owner | Hyperion Therapeutics Inc (HPTX) | 04-May-15 | Gift | 6,849 | -- | -- | (< 1%) 1.95M to 1.94M | |
| 05-May-15 5:35 PM View: | Farrow Jeffrey S CFO | Hyperion Therapeutics Inc (HPTX) | 01-May-15 | Option Exercise | 120,777 | $3.45 | $416,347.00 | 511% 23.63K to 144.4K | |
| 05-May-15 5:35 PM View: | Scharschmidt Bruce Frederick SVP & Chief Medical Officer | Hyperion Therapeutics Inc (HPTX) | 01-May-15 | Option Exercise | 6,975 | $6.30 | $43,926.50 | 6% 121.92K to 128.89K | |
| 05-May-15 5:35 PM View: | Santel Donald J CEO & President Director | Hyperion Therapeutics Inc (HPTX) | 01-May-15 | Option Exercise | 292,057 | $2.31 | $675,573.00 | 438% 66.64K to 358.7K | |
| 05-May-15 5:35 PM View: | Nash Christine A SVP & Chief Commercial Officer | Hyperion Therapeutics Inc (HPTX) | 01-May-15 | Option Exercise | 59,087 | $4.97 | $293,449.00 | 160% 37.0K to 96.09K | |
| 17-Mar-15 5:20 PM View: | Nash Christine A SVP & Chief Commercial Officer | Hyperion Therapeutics Inc (HPTX) | 17-Mar-15 | Option Exercise | 10,000 | $4.08 | $40,800.00 | 53% 19.0K to 29.0K | |
| 17-Mar-15 5:20 PM View: | Nash Christine A SVP & Chief Commercial Officer | Hyperion Therapeutics Inc (HPTX) | 17-Mar-15 | Market Option Sale (Planned) | 10,000 | $37.56 | $375,600.00 | (34%) 29.0K to 19.0K | < 1% |
| 13-Mar-15 7:22 PM View: | Nash Christine A SVP & Chief Commercial Officer | Hyperion Therapeutics Inc (HPTX) | 10-Mar-15 | Option Exercise | 10,000 | $4.08 | $40,800.00 | 53% 19.0K to 29.0K | |
| 13-Mar-15 7:22 PM View: | Nash Christine A SVP & Chief Commercial Officer | Hyperion Therapeutics Inc (HPTX) | 10-Mar-15 | Planned Private Option Sale | 10,000 | $35.08 | $350,800.00 | (34%) 29.0K to 19.0K | |
| 10-Mar-15 7:37 PM View: | Nash Christine A SVP & Chief Commercial Officer | Hyperion Therapeutics Inc (HPTX) | 10-Mar-15 | Market Sale (Planned) | 1,450 | $30.10 | $43,645.00 | (7%) 20.45K to 19.0K | < 1% |
| 10-Mar-15 7:37 PM View: | Nash Christine A SVP & Chief Commercial Officer | Hyperion Therapeutics Inc (HPTX) | 09-Mar-15 | Market Sale (Planned) | 8,450 | $29.55 | $249,658.00 | (29%) 28.9K to 20.45K | (55%) |
| 03-Mar-15 6:32 PM View: | Scharschmidt Bruce Frederick SVP & Chief Medical Officer | Hyperion Therapeutics Inc (HPTX) | 27-Feb-15 | Market Sale | 29,800 | $29.89 | $890,817.00 | (16%) 180.97K to 151.17K | (< 1%) |
| 10-Feb-15 9:36 PM View: | Farrow Jeffrey S CFO | Hyperion Therapeutics Inc (HPTX) | 09-Feb-15 | Grant | 18,000 | -- | -- | 320% 5.63K to 23.63K |
